Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  2004-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/ard.2004.023119PMID 15231512PMCID PMC1755332
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

  2003cited by this paper
• Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study.

  2002cited by this paper
• Atherosclerosis in rheumatoid arthritis - Morphologic evidence obtained by carotid ultrasound

  2002cited by this paper
• Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis.

  2002cited by this paper
• Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound.

  2002cited by this paper
• Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?

  2002cited by this paper
• Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis.

  2002cited by this paper
• Anti–Tumor Necrosis Factor-&agr; Treatment Improves Endothelial Function in Patients With Rheumatoid Arthritis

  2002cited by this paper
• Anti–Tumor Necrosis Factor-α Treatment Improves Endothelial Function in Patients With Rheumatoid Arthritis

  2002cited by this paper
• Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.

  2002cited by this paper
• Infection and inflammation-induced proatherogenic changes of lipoproteins.

  2000cited by this paper
• Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

  2000cited by this paper
• Precipitation methods for high-density lipoprotein cholesterol measurement compared, and final evaluation under routine operating conditions of a method with a low sample-to-reagent ratio.

  1997cited by this paper
• Cholesterol and Coronary Heart Disease: Predicting Risks by Levels and Ratios

  1994cited by this paper
• Tumor necrosis factor, cytokines, and the hyperlipidemia of infection.

  1991cited by this paper
• Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism.

  1988cited by this paper

• Biologic Therapy and Cardiometabolic Risk in Psoriasis: A Retrospective Review

  2025cites this paper
• Comparative effects of biological and targeted synthetic DMARDs on incident chronic kidney disease in patients with rheumatoid arthritis.

  2024cites this paper
• Eye on the horizon: The metabolic landscape of the RPE in aging and disease

  2024cites this paper
• Lipid metabolism and rheumatoid arthritis

  2023cites this paper
• Dyslipidemia in rheumatoid arthritis: the possible mechanisms

  2023cites this paper
• Impact of anti-tumor necrosis factor treatment on lipid profiles in Korean patients with ankylosing spondylitis

  2023cites this paper
• Physical exercise attenuates obesity development in Western‐diet fed obese rats independently of vitamin D supplementation

  2022cites this paper
• TNF-Alpha Inhibitors and Ustekinumab for the Treatment of Psoriasis: Therapeutic Utility in the Era of IL-17 and IL-23 Inhibitors

  2022cites this paper
• Randomized clinical trials on the efficacy and safety of tocilizumab in subjects with rheumatoid arthritis: a systematic review.

  2022cites this paper
• Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022

  2022cites this paper
• The Effects of 21-Day General Rehabilitation after Hip or Knee Surgical Implantation on Plasma Levels of Selected Interleukins, VEGF, TNF-α, PDGF-BB, and Eotaxin-1

  2022cites this paper
• Augmentation index, but not pulse wave velocity, is associated with disease activity in rheumatoid arthritis

  2022cites this paper
• Inflammatory basis of atherosclerosis: modulation by sex hormones.

  2021cites this paper
• Improvements in High-Density Lipoprotein Quantity and Quality Contribute to the Cardiovascular Benefits by Anti-tumor Necrosis Factor Therapies in Rheumatoid Arthritis: A Systemic Review and Meta-Analysis

  2021cites this paper
• Influence of anti-TNF therapy and homocysteine level on carotid intima-media thickness in rheumatoid arthritis patients.

  2021cites this paper
• Association of Rheumatoid Arthritis with Diabetic Comorbidity: Correlating Accelerated Insulin Resistance to Inflammatory Responses in Patients

  2021cites this paper
• The impact of anti-TNFα agents on weight-related changes: new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) database

  2021cites this paper
• [Clinicopatological variants and risk factors for chronic kidney disease in rheumatoid arthritis].

  2020cites this paper
• Circulating level of interleukin-6 in relation to body mass indices and lipid profile in Egyptian adults with overweight and obesity

  2020cites this paper
• Inflammation in Cardiovascular Disease: From Basic Concepts to Clinical Application

  2020cites this paper
• Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities

  2020cites this paper
• The Lipid Paradox as a Metabolic Checkpoint and Its Therapeutic Significance in Ameliorating the Associated Cardiovascular Risks in Rheumatoid Arthritis Patients

  2020cites this paper
• Effects of TNF-α antagonist infliximab on fructose-induced metabolic syndrome in rats

  2020cites this paper
• Obesity: Role of Tumor Necrosis Factor-α and of Other Adipocytokines Involved in the Chronic Inflammation and the Immune and Metabolic Dysregulation

  2019cites this paper
• Effect of Eight Weeks Resistance Training On Gene Expression of TNF-Α and IL10 in the Heart of Type II Diabetic Male Rats

  2019cites this paper
• Triglyceride-to-High-Density Lipoprotein Cholesterol Ratio and Systemic Inflammation in Patients with Idiopathic Pulmonary Arterial Hypertension

  2019cites this paper
• Management of psoriasis as a systemic disease: what is the evidence?

  2019cites this paper
• Serum and expression profiles of glucose-dependent insulinotropic polypeptide in correlation with cardiometabolic risk factors among patients with systemic lupus erythematosus

  2019cites this paper
• The effect of tumor necrosis factor inhibitor therapy on the incidence of myocardial infarction in patients with psoriasis: a retrospective study

  2018cites this paper
• Riferimenti bibliografici

  2018cites this paper
• 2-D speckle-tracking assessment of left and right ventricular function in rheumatoid arthritis patients with and without disease activity

  2018cites this paper
• Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic Review

  2018cites this paper
• Potential therapeutic roles of 10-dehydrogingerdione and/or pentoxifylline against calcium deposition in aortic tissues of high dietary cholesterol-fed rabbits

  2018cites this paper
• Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease.

  2018cites this paper
• Therapeutic Approaches Targeting Inflammation in Cardiovascular Disorders

  2018cites this paper
• Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis

  2018cites this paper
• High‑density lipoprotein cholesterol levels and pulmonary artery vasoreactivity in patients with idiopathic pulmonary arterial hypertension.

  2018cites this paper
• Cardiac Effects of Antirheumatic Drugs

  2017cites this paper
• The Therapeutic Potential of Anti-Inflammatory Exerkines in the Treatment of Atherosclerosis

  2017cites this paper
• New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis

  2017cites this paper
• Subclinical Cardiovascular Damage in Systemic Rheumatic Diseases

  2017cites this paper
• Aquaporin-3 expression in common hyperproliferative skin disorders: an immunohistochemical study

  2017cites this paper
• Cardiovascular disease in rheumatoid arthritis: risk profile and risk prediction

  2017influential citation
• Effects of anti-TNF-α treatment on lipid profile in rheumatic diseases: an analytical cohort study

  2016cites this paper
• The role of inflammatory biomarkers in developing targeted cardiovascular therapies: lessons from the cardiovascular inflammation reduction trials.

  2016cites this paper
• Immuno-Inflammatory Basis of Atherosclerotic Coronary Artery Disease

  2016cites this paper
• Gestión de riesgo para la prescripción de terapias biológicas

  2016cites this paper
• Cardiovascular outcomes and tumour necrosis factor antagonists in chronic inflammatory rheumatic disease: a focus on rheumatoid arthritis

  2016cites this paper
• The Assessment of Subclinical Cardiovascular Dysfunction in Treated Rheumatoid Arthritis.

  2016cites this paper
• Remodeling of plasma lipoproteins in patients with rheumatoid arthritis: Interleukin‐6 receptor‐alpha inhibition with tocilizumab

  2016cites this paper
• Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study

  2016cites this paper
• Risk management for prescribing biological therapies

  2016cites this paper
• Blockade of the neuropeptide Y Y2 receptor with the potent antagonist BIIE0246 regulates gene expression levels in the lipid metabolic pathways in human hepatoma cell line HepG2

  2016cites this paper
• Exercise ameliorates high fat diet induced cardiac dysfunction by increasing interleukin 10

  2015cites this paper
• Lipid Profile Changes in Patients With Chronic Inflammatory Arthritis Treated With Biologic Agents and Tofacitinib in Randomized Clinical Trials: A Systematic Review and Meta‐Analysis

  2015cites this paper
• Molecular regulation of Nox1 NADPH oxidase in vascular smooth muscle cell activation

  2015cites this paper
• Prevention of Stroke in Rheumatoid Arthritis

  2015cites this paper
• Omega-3 fatty acids and inflammation: a perspective on the challenges of evaluating efficacy in clinical research.

  2015cites this paper
• Remission of Uncontrolled Type 2 Diabetes Mellitus in a Patient Treated with Tumor Necrosis Factor-Inhibitor: A Case Report

  2015cites this paper
• Immune-Mediated Inflammatory Diseases and Other Comorbidities in Patients With Psoriasis: Baseline Characteristics of Patients in the AQUILES Study

  2015cites this paper
• Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis

  2015cites this paper
• Mechanisms of Cardiotoxicity and the Development of Heart Failure.

  2015cites this paper
• Cardiovascular Risk Factors in Chronic Inflammatory Rheumatic Diseases: Modern Assessment and Diagnosis.

  2015cites this paper
• Immune-mediated inflammatory diseases and other comorbidities in patients with psoriasis: baseline characteristics of patients in the AQUILES study.

  2015cites this paper
• Lipid Profile in Inflammatory Bowel Disease Patients on Anti-TNFα Therapy

  2015cites this paper
• Prevention of Stroke in Rheumatoid Arthritis

  2015cites this paper
• Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis

  2015cites this paper
• Prostaglandins and Other Lipid Mediators eview mega-3 fatty acids and inflammation : A perspective on the hallenges of evaluating efficacy in clinical research

  2015cites this paper
• Increased cardiovascular risk in patients with rheumatoid arthritis: an overview

  2014cites this paper
• Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment

  2014cites this paper
• Infliximab Reverses Suppression of Cholesterol Efflux Proteins by TNF-α: A Possible Mechanism for Modulation of Atherogenesis

  2014cites this paper
• Relationship between tumor necrosis factor-α inhibitors and cardiovascular disease in psoriasis: a review.

  2014cites this paper
• Lipid Profiles Alter from Pro-Atherogenic into Less Atherogenic and Proinflammatory in Juvenile Idiopathic Arthritis Patients Responding to Anti TNF-α Treatment

  2014cites this paper
• Lipid profile changes in patients with rheumatic diseases receiving a treatment with TNF-α blockers: A meta-analysis of prospective studies

  2014cites this paper
• Prevalence of lipid phenotypes, serum lipid behaviour over follow-up and predictors of serum lipid levels in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease-modifying anti-rheumatic drugs.

  2014cites this paper
• Molecular Determinants of Atherosclerosis

  2014cites this paper
• Anti-inflammatory therapies for cardiovascular disease.

  2014cites this paper
• Opportunity nox: the future of NADPH oxidases as therapeutic targets in cardiovascular disease.

  2013cites this paper
• Visfatin and adiponectin as novel markers for evaluation of metabolic disturbance in recently diagnosed rheumatoid arthritis patients

  2013cites this paper
• Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis.

  2013cites this paper
• Dietary fat modulates the relationship between polymorphisms in the TNFA and IL-6 genes, and obesity and serum lipid concentrations in black and white South Afican women

  2013cites this paper
• TNF Antagonists, The Prevention of Myocardial Infarction in Rheumatoid Arthritis Patients?

  2013cites this paper
• Vascular endothelium--role in chronic inflammatory disease.

  2013cites this paper
• Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammation

  2013cites this paper
• Association of 25-hydroxyvitamin D serum levels and metabolic parameters in psoriatic patients with and without arthritis.

  2013cites this paper
• From guidelines to clinical practice: cardiovascular risk management in inflammatory arthritis patients.

  2013cites this paper
• Lipid profiles in untreated patients with dermatomyositis

  2013cites this paper
• Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis

  2013cites this paper
• Emerging anti-inflammatory drugs for atherosclerosis

  2013cites this paper
• The Relationship between Dietary Fatty Acids and Inflammatory Genes on the Obese Phenotype and Serum Lipids

  2013cites this paper
• Atherogenic Index and High-Density Lipoprotein Cholesterol as Cardiovascular Risk Determinants in Rheumatoid Arthritis: The Impact of Therapy with Biologicals

  2012cites this paper
• Effect of pomegranate seed oil on serum TNF-α level in dyslipidemic patients

  2012cites this paper
• The roles of cells and cytokines in the pathogenesis of psoriasis

  2012cites this paper
• Beyond the joints in rheumatoid arthritis: Effects of adalimumab on hematologic and lipid indices

  2012cites this paper
• Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti–tumor necrosis factor therapy

  2012cites this paper
• Metabolic syndrome in rheumatoid arthritis.

  2012cites this paper
• Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis

  2012cites this paper
• [Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities].

  2012cites this paper
• Cardiovascular risk in patients with rheumatoid arthritis: assessment of several traditional risk parameters and a German risk score model

  2012cites this paper
• Integrated Approach to Comorbidity in Patients With Psoriasis

  2012cites this paper